astepro

Year-round symptom relief

  • Indicated for both seasonal and perennial allergic rhinitis
astepro

Steroid-free therapy without an added decongestant

astepro

ASTEPRO 0.15% has no generic equivalent

  • Contains 50% higher concentration of azelastine HCI per spray than ASTEPRO 0.1%

When prescribed for SAR

  • Patients aged 12 and older
    • 1 or 2 sprays per nostril twice daily
    • 2 sprays per nostril once daily
  • Patients aged 6 to 11
    • 1 spray per nostril twice daily

 
 

For Physicians

#1 Branded Antihistamine

For Pharmacists

Highest Tier 2 availability

For Patients

Read more about ASTEPRO 0.15% and the allergy symptom relief it delivers
 

Copay Savings

Most eligible patients will pay no more than $35 per copay*
*Restrictions may apply.

 

*
Restrictions may apply. Patients are not eligible if prescriptions are paid by any state or federally funded programs, including, but not limited to, Medicare or Medicaid, Medigap, VA, DoD or TriCare, or where prohibited by law.

Indication

ASTEPRO (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 6 years of age and older.

Important Safety Information

  • Avoid engaging in hazardous occupations requiring complete mental alertness and motor coordination such as operating machinery or driving a motor vehicle. 
  • Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%. 
  • In clinical studies of adults and adolescents 12 years of age and older, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%).
  • In clinical studies of children 6 to 11 years of age, the most commonly reported adverse reactions, when dosed at 1 spray per nostril twice a day, included epistaxis (4%), nasal discomfort (4%), dysgeusia (4%), upper respiratory infection (3%), and sneezing (3%).  
  • Pregnancy Category C: Based on animal data; may cause fetal harm. 
Please see full Prescribing Information
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088

For more information about ASTEPRO Nasal Spray 0.15%, call Meda Pharmaceuticals Inc. at 1-800-526-3840.